The relationship between oestrogen replacement therapy and breast cancer risk was examined based on data obtained from a population-based case-control study of breast cancer on Long Island, New York, USA.
Cases were defined as female residents of two Long Island counties, aged 20-79, who were diagnosed with breast cancer between 1 January 1984 and 31 December 1986.
Age- and county-matched controls were selected from driver's licence files.
Among all postmenopausal women, there was no significant association between ever-use of hormones to treat menopausal symptoms and breast cancer risk.
Mots-clés Pascal : Tumeur maligne, Glande mammaire, Glande mammaire pathologie, Oestrogène, Hormone stéroïde sexuelle, Traitement substitutif, Epidémiologie, Homme, Femelle, New York, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Malignant tumor, Mammary gland, Mammary gland diseases, Estrogen, Sex steroid hormone, Replacement therapy, Epidemiology, Human, Female, New York, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0058833
Code Inist : 002B20E02. Création : 199406.